Aubrey, R. E., Psarianos, P., Santiago, A. T., Griffin, A. M., Ferguson, P. C., Gupta, A. A., . . . Shultz, D. B. (2026). Outcomes following definitive treatment of malignant peripheral nerve sheath tumor are significantly worse for patients with neurofibromatosis type 1: A Canadian Sarcoma Research and Clinical Collaboration study. Cancer (0008543X), 132(3), 1. https://doi.org/10.1002/cncr.70263
Chicago Style (17th ed.) CitationAubrey, Rachel E., Pamela Psarianos, Anna T. Santiago, Anthony M. Griffin, Peter C. Ferguson, Abha A. Gupta, Hagit Peretz Soroka, and David B. Shultz. "Outcomes Following Definitive Treatment of Malignant Peripheral Nerve Sheath Tumor Are Significantly Worse for Patients with Neurofibromatosis Type 1: A Canadian Sarcoma Research and Clinical Collaboration Study." Cancer (0008543X) 132, no. 3 (2026): 1. https://doi.org/10.1002/cncr.70263.
MLA (9th ed.) CitationAubrey, Rachel E., et al. "Outcomes Following Definitive Treatment of Malignant Peripheral Nerve Sheath Tumor Are Significantly Worse for Patients with Neurofibromatosis Type 1: A Canadian Sarcoma Research and Clinical Collaboration Study." Cancer (0008543X), vol. 132, no. 3, 2026, p. 1, https://doi.org/10.1002/cncr.70263.